Aesthetic devices refer to the devices that are used in cosmetic procedures for beautification, correction and improvement of body contour which includes fillers, breast implants, facial implants and penile implants. Aesthetic injectables refer to gel-such as substances that are injected beneath the skin to restore a more youthful appearance. This includes fillers and Botox. GlobalData uses proprietary data and analytics to provide a comprehensive report on the aesthetic injectables devices market, including market shares of different players within France. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the aesthetic injectables market in France was Galderma followed by Allergan Aesthetics, Merz Pharma GmbH & Co, Sinclair Pharma and Teoxane.
Aesthetic Injectables achieved a benefit by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour. Aesthetic injectables are grouped into segments based on their molecular composition. Aesthetic injectables include Botulinum Toxin Type A , Hyaluronic Acid (HA) fillers, and Non-Hyaluronic Acid fillers.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the aesthetic injectables devices market within France was expected to be over $100m in 2022.
For the latest complete market share analysis of aesthetic injectables device market in France, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
